Former President Joe Biden diagnosed with ‘aggressive’ form of prostate cancer

Former President Joe Biden diagnosed with ‘aggressive’ form of prostate cancer


Former President Joe Biden speaks during the Advocates, Counselors, and Representatives for the Disabled bipartisan conference at the Sofitel Chicago Magnificent Mile on Tuesday, April 15, 2025.

Eileen T. Meslar | Chicago Tribune | Getty Images

Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday.

Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone. His office said he has stage 9 cancer.

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” his office said. “The President and his family are reviewing treatment options with his physicians.”

Prostate cancers are given a score called a Gleason score that measures, on a scale of 1 to 10, how the cancerous cells look compared with normal cells. Biden’s score of 9 suggests his cancer is among the most aggressive.

When prostate cancer spreads to other parts of the body, it often spreads to the bones. Metastasized cancer is much harder to treat than localized cancer because it can be hard for drugs to reach all the tumors and completely root out the disease.

However, when prostate cancers need hormones to grow, as in Biden’s case, they can be susceptible to treatment that deprives the tumors of hormones.

The health of Biden, 82, was a dominant concern among voters during his time as president. After a calamitous debate performance in June while seeking reelection, Biden abandoned his bid for a second term. Then-Vice President Kamala Harris became the nominee and lost to Republican Donald Trump, who returned to the White House after a four-year hiatus.

But in recent days, Biden rejected concerns about his age despite reporting in the new book “Original Sin” by Jake Tapper and Alex Thompson that aides had shielded the public from the extent of his decline while serving as president.

In February 2023, Biden had a skin lesion removed from his chest that was a basal cell carcinoma, a common form of skin cancer. And in November 2021, he had a polyp removed from his colon that was a benign, but potentially pre-cancerous lesion.

In 2022, Biden made a “cancer moonshot” one of his administration’s priorities with the goal of halving the cancer death rate over the next 25 years. The initiative was a continuation of his work as vice president to address a disease that had killed his older son, Beau.



Source

Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest
World

Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest

Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early Friday after a legal threat from Novo Nordisk. The online teleheath company announced on Thursday plans to launch a cheaper, copycat version of Novo’s weight loss pill, prompting Novo to take legal action. Hims stock spiked as […]

Read More
Goldman Sachs is tapping Anthropic’s AI model to automate accounting, compliance roles
World

Goldman Sachs is tapping Anthropic’s AI model to automate accounting, compliance roles

Goldman Sachs has been working with the artificial intelligence startup Anthropic to create AI agents to automate a growing number of roles within the bank, the firm’s tech chief told CNBC exclusively. The bank has, for the past six months, been working with embedded Anthropic engineers to co-develop autonomous agents in at least two specific […]

Read More
Anduril founder says U.S. can spend billions less on defense: ‘We spend too much money on the wrong thing’
World

Anduril founder says U.S. can spend billions less on defense: ‘We spend too much money on the wrong thing’

Defense spending has been the talk of Singapore’s Airshow this week but that’s not an accurate way to measure military strength, Palmer Luckey, founder of defense tech firm Anduril Industries, said on CNBC’s “Squawk Box Asia” Wednesday. That comes after U.S. President Donald Trump in January expressed interest in raising the U.S military budget to […]

Read More